VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,453,000 | +84.6% | 100,000 | +75.1% | 0.04% | +65.4% |
| Q1 2023 | $1,328,717 | -23.4% | 57,100 | -36.6% | 0.03% | +8.3% |
| Q3 2022 | $1,734,000 | +127.0% | 90,000 | +200.0% | 0.02% | +118.2% |
| Q2 2022 | $764,000 | -91.1% | 30,000 | -85.3% | 0.01% | -88.5% |
| Q4 2021 | $8,552,000 | +486.6% | 204,300 | +509.9% | 0.10% | +464.7% |
| Q3 2021 | $1,458,000 | -59.4% | 33,500 | -55.9% | 0.02% | -63.8% |
| Q2 2021 | $3,594,000 | -52.0% | 76,000 | -47.9% | 0.05% | -70.8% |
| Q1 2021 | $7,488,000 | – | 146,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |